Metal oxide nanocatalysts for the electrochemical detection of propofol

Ferrier, David; Kiely, Janice; Luxton, Richard

Abstract

Propofol is one of the most widely used intravenous drugs for anaesthesia and sedation and is one of the most commonly used drugs in intensive care units for the sedation of mechanically ventilated patients. The correct dosage of propofol is of high importance, but there is currently a lack of suitable point-of-care techniques for determining blood propofol concentrations. Here, we present a cytochrome P450 2B6/carbon nanotube/graphene oxide/metal oxide nanocomposite sensor for discrete measurement of propofol concentration. Propofol is converted into a quinol/quinone redox couple by the enzyme and the nanocomposite enables sensitive and rapid detection. The metal oxide nanoparticles are synthesised via green synthesis and a variety of metal oxides and mixed metal oxides are investigated to determine the optimal nanocatalyst. Converting propofol into the redox couple allows for the measurement to take place over different potential ranges, enabling interference from common sources such as paracetamol and uric acid to be avoided. It was found that nanocomposites containing copper titanium oxide nanoparticles offered the best overall performance and electrodes functionalised with such nanocomposites demonstrated a limit of detection in bovine serum of 0.5 μg/mL and demonstrated a linear response over the therapeutic range of propofol with a sensitivity of 4.58 nA/μg/mL/mm2.

• Journal Article Type: Article
• Acceptance Date: Jan 18, 2025
• Online Publication Date: Jan 22, 2025
• Publication Date: Jan 22, 2025
• Deposit Date: Jan 22, 2025
• Publicly Available Date: Jan 22, 2025
• Electronic ISSN: 2072-666X
• Publisher: MDPI
• Peer Reviewed: Peer Reviewed
• Volume: 16
• Issue: 2
• Article Number: 120
• DOI: https://doi.org/10.3390/mi16020120
• Public URL: https://uwe-repository.worktribe.com/output/13634307